Behandlungsverfahren mit Adoptiver Zelltherapie
EP4775670
15. Juli 2026
Anmelder: Juno Therapeutics, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4775670
- Anmeldetag
- 29. November 2019
- Veröffentlichung
- 15. Juli 2026
- Rechtsraum
- EP
- IPC
- C12N5/0783
Abstract
Provided are adoptive cell therapy involving the administration of doses of cells for treating subjects with disease and conditions such as certain B cell malignancies, and related methods, compositions, uses and articles of manufacture. The cells generally express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the disease or condition is a large B cell lymphoma, such as a diffuse large B-cell lymphoma (DLBCL). Also provided are methods of assessing the risk of developing a toxicity related to a cell therapy, and methods of identifying subjects and methods of treating subjects based on the assessment of risks.
Anmelder
- Firma
- Juno Therapeutics, Inc.
- Land
- 🇺🇸 USA